Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
| dc.Type | Article | pt_BR |
| dc.contributor.author | Amorim, Viviane Brandão | |
| dc.contributor.author | Parente, Daniella Braz | |
| dc.contributor.author | Paiva, Fernando Fernandes | |
| dc.contributor.author | Oliveira Neto, Jaime Araújo | |
| dc.contributor.author | Miranda, Amanda Almeida | |
| dc.contributor.author | Moreira, Cláudia Cravo | |
| dc.contributor.author | Fernandes, Flávia Ferreira | |
| dc.contributor.author | Campos, Carlos Frederico Ferreira | |
| dc.contributor.author | Leite, Nathalie Carvalho | |
| dc.contributor.author | Perez, Renata de Mello | |
| dc.contributor.author | Rodrigues, Rosana Souza | |
| dc.date.accessioned | 2022-08-19T12:42:30Z | |
| dc.date.available | 2022-08-19T12:42:30Z | |
| dc.date.issued | 2020 | |
| dc.description | p. 661-671.: il. p&b. | |
| dc.description.abstract | Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. The diagnosis of nonalcoholic steatohepatitis (NASH), the most severe form of NAFLD, is crucial and has prognostic and therapeutic implications. However, currently this diagnosis is based on liver biopsy and has several limitations. | |
| dc.identifier.citation | AMORIM, Viviane Brandão et al. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World J Hepatol, v. 12, n. 9, p. 661-671, 2020. | |
| dc.identifier.issn | 1948-5182 | |
| dc.identifier.uri | http://sr-vmlxaph03:8080/jspui/handle/123456789/10244 | |
| dc.publisher | World J Hepatol | pt_BR |
| dc.subject | Fígado Gorduroso | pt_BR |
| dc.subject | Fatty Liver | pt_BR |
| dc.subject | Hepatopatia Gordurosa não Alcoólica | pt_BR |
| dc.subject | Non-alcoholic Fatty Liver Disease | pt_BR |
| dc.subject | Gadolínio DTPA | pt_BR |
| dc.subject | Gadolinium DTPA | pt_BR |
| dc.title | Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? | pt_BR |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver.pdf
- Size:
- 1.84 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.6 KB
- Format:
- Item-specific license agreed upon to submission
- Description: